title: Importance of experiments in poliovirus-susceptible transgenic mice for evaluating current potency tests of inactivated polio vaccine (IPV).
authors.affiliation: FDA, Rockville, MD, USA.
authors.forename: R
authors.initials: R
authors.lastname: Taffs
authors.forename: E
authors.initials: E
authors.lastname: Dragunsky
authors.forename: T
authors.initials: T
authors.lastname: Nomura
authors.forename: K
authors.initials: K
authors.lastname: Hioki
authors.forename: I
authors.initials: I
authors.lastname: Levenbook
authors.forename: E
authors.initials: E
authors.lastname: Fitzgerald
mesh_terms: D000826:Animal Testing Alternatives / Q000379:methods*; D000818:Animals; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D011051:Poliomyelitis / Q000276:immunology / Q000517:prevention & control; D011054:Poliovirus Vaccine, Inactivated / Q000032:analysis / Q000494:pharmacology*; D011991:Receptors, Virus / Q000235:genetics; D015164:Vaccines, Inactivated / Q000032:analysis / Q000494:pharmacology
chemical_list: D011054:Poliovirus Vaccine, Inactivated; D011991:Receptors, Virus; D015164:Vaccines, Inactivated